Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
Back
ePoster
P285
Rimegepant for the acute treatment of migraine – a phase 3, multicenter, open-label, long-term safety study in adults from China
Shengyuan Yu
Beijing, CN
Appointment
Date:
06.12.
Time:
12:35
–
12:40
Talk time:
3 Min.
Discussion time:
2 Min.
Location / Stream:
ePoster station 4
Poster
Rimegepant for the acute treatment of migraine – a phase 3, multicenter, open-label, long-term safety study in adults from China
Session
ePoster 04
Topic
New clinical developments in prophylactic and acute medications
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy